genprowebdirectory
Facebook Linkedin RSS Twitter Youtube
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Facebook Linkedin RSS Twitter Youtube
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home 2021

Multiple myeloma

Antisense Oligo Targets IRF4 Gene to Treat Multiple Myeloma
Cancer

Antisense Oligo Targets IRF4 Gene to Treat Multiple Myeloma

Collaborating for Filtration Success, Virtually
News

Collaborating for Filtration Success, Virtually

Kleo Pharmaceuticals and Green Cross LabCell (GCLC)–65
News

Kleo Pharmaceuticals and Green Cross LabCell (GCLC)–65

Karyopharm Therapeutics – XPOVIO®
News

Karyopharm Therapeutics – XPOVIO®

Allogene, Notch Partner to Develop iPSC-Derived Blood Cancer Therapies
Cancer

Allogene, Notch Partner to Develop iPSC-Derived Blood Cancer Therapies

Liquid Biopsy Technologies Diversify in Expanding CTC Field
Bioprocessing

Liquid Biopsy Technologies Diversify in Expanding CTC Field

Janssen, Genmab Partner on Follow-On to Darzalex for Multiple Myeloma, Diffuse Large B-Cell Lymphoma
Cancer

Janssen, Genmab Partner on Follow-On to Darzalex for Multiple Myeloma, Diffuse Large B-Cell Lymphoma

Strategies for Preventing Dormant Cancer Cells from Being Reactivated
Cancer

Strategies for Preventing Dormant Cancer Cells from Being Reactivated

AbbVie to Co-Develop Teneobio’s Lead Candidate for Multiple Myeloma, Gains Acquisition Option
Cancer

AbbVie to Co-Develop Teneobio’s Lead Candidate for Multiple Myeloma, Gains Acquisition Option

argenx Plans Autoimmune Treatments Using Halozyme’s ENHANZE Drug-Delivery Technology
Drug Discovery

argenx Plans Autoimmune Treatments Using Halozyme’s ENHANZE Drug-Delivery Technology

1234...15Page 3 of 15

Read the Digital Edition

August 2023 cover

Explore

  • About GEN
  • Contact GEN
  • GEN Staff
  • Editorial Guidelines
  • Reprints and Permissions
  • Scientific Advisory Board

Advertise

  • Media Kit and Planning Calendar
  • Advertising Terms and Conditions

Resources

  • Get the GEN Magazine
  • Get the GEN Email Newsletter
  • Inside Precision Medicine
  • Privacy Policy
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up